HTT and Huntington disease: Collectively, our results are consistent with the hypothesis that HEK293 cells express a novel protease that cleaves htt between amino acids 105 and 114 to produce an htt fragment that possesses antibody-binding properties that are identical to the primary pathologic fragment that produces inclusions in HD brain [8].